Alpha Cognition Inc (TSE:ACOG) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alpha Cognition Inc. has announced the partial exercise of its over-allotment option, resulting in the sale of an additional 488,506 shares at $5.75 per share, raising an extra $2.8 million in gross proceeds. In total, the company sold over 9 million shares, generating approximately $52.8 million to support the commercialization of its Alzheimer’s drug ZUNVEYL and further research. The shares, trading under the ticker ACOG on Nasdaq, aim to bolster the company’s resources for advancing its neurodegenerative treatment pipeline.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
